Santhera Pharmaceuticals

This program provides continued access to the drug vamorolone for boys with Duchenne muscular dystrophy (DMD) who have already taken it in previous clinical studies. It allows them to keep receiving the medication while it is being reviewed for full market approval. The goal is t…